Intellectual Property India Publishes Patent Application for 'Antibodies Against Cldn4 And Methods Of Use Thereof' Filed by Dana-Farber Cancer Institute, Inc.

MUMBAI, India, June 20 -- Intellectual Property India has published a patent application (202517023146 A) filed by Dana-Farber Cancer Institute, Inc., Boston, on March 15, for 'antibodies against cldn4 and methods of use thereof.'

Inventor(s) include Marasco, Wayne A.; and Chang, Matthew.

The application for the patent was published on June 20, under issue no. 25/2025.

According to the abstract released by the Intellectual Property India: "The present invention comprises human antibodies that bind to Claudin 4 domains (CLDN4) protein. The antibodies can be used to treat cancer."

The patent application was internationally filed on Aug. 15, 2023, under International application No.PCT/US2023/030265.

Disclaimer: Curated by HT Syndication.